"We are inspired by the difference that we can makein the lives of people through the innovative medicinesthat we discover and develop."



Please find links to PDF's of our Investor Events below..



2010 | 2009 | 2008 | 2007 | 2006 | 2005

April 2010 Results of Annual General Meeting
April 2010 Total Voting Rights
April 2010 Additional Listing
April 2010 2009 Annual Report
April 2010 Proximagen Sublicenses Rights to Tonabersat
Mar 2010 Grant of New Share Options
Mar 2010 Notification of Preliminary Results
Mar 2010 Proximagen announces positive efficacy results in NIH epilepsy studies
Mar 2010 Compulsory Acquisition of Outstanding Minster Shares
Feb 2010 Offer for Minster declared unconditional
Feb 2010 Strategic Update
Feb 2010 Board Changes
Jan 2010 Form of Acceptance
Jan 2010 Recommended Cash Offer Document
Jan 2010 Posting of Offer Document
Jan 2010 Recommended Cash Offer for Minster Pharmaceuticals Plc
Nov 2009 Completion of Acquisition of Cambridge Biotechnology Ltd
Oct 2009 Proximagen Acuires Cambridge Biotechnology Ltd
Oct 2009 Letter of Intent to acquire Cambridge Biotechnology
July 2009 Total Voting Rights
July 2009 2009 Interim Results
June 2009 Major Interest in Shares
June 2009 Major Interest in Shares
June 2009 Major Interest in Shares
June 2009 Major Interest in Shares
June 2009 Major Interest in Shares
June 2009 Major Interest in Shares
June 2009 Result of General Meeting
June 2009 Proxy Voting Form
June 2009 Circular to Shareholders
June 2009 Proximagen Raises �50M
May 2009 Result of AGM
May 2009 Change of Broker
May 2009 Notice of Annual Report and Accounts
April 2009 2008 Annual Report
Mar 2009 2008 Preliminry Results
Feb 2009 Major Interest in Shares
Feb 2009 Major Interest in Shares
Jan 2009 Board Changes
Dec 2008 Directors' Share Purchase
Nov 2008 Major Interest in Shares
Oct 2008 Issue of Equity
Oct 2008 Grant of Options
Oct 2008 Milestone and equity investment
Sept 2008 Declaration of Major Shareholding
Aug 2008 2008 Interim Results
Aug 2008 Notice of Results
July 2008 Declaration of Major Shareholding
July 2008 Proximagen Signs $232 Million Licensing Agreement with Upsher-Smith
April 2008 Proximagen 2008 AGM Proxy form
April 2008 Notice of 2008 AGM
April 2008 2008 AGM Cover Letter
April 2008 2007 Annual Report
April 2008 Preliminary Results
January 2008 Change of Nomad and Broker
December 2007 Director/PDMR Shareholding
December 2007 Partnership Agreement
December 2007 Termination of Offer Period
October 2007 Total Voting Rights
September 2007 Additional Listing
September 2007 Rule 8.3- Proximagen
August 2007 2007 Interim Statement
August 2007 Disclosure of Information
August 2007 Notice of Interim Results
July 2007 Total Voting Rights
July 2007 Statement RE: Possible Offer
July 2007 MJFF Grant, Elan Option
June 2007 Holding(s) in Company
June 2007 Holding(s) in Company
April 2007 Additional Listing
April 2007 AGM Statement
April 2007 Annual Report and AGM Date
April 2007 Holding(s) in Company
March 2007 Holding(s) in Company
March 2007 Holding(s) in Company
March 2007 Holding(s) in Company
March 2007 Annual Report and AGM Date
March 2007 2006 Annual Report
February 2007 2006 Preliminary results
February 2007 Holding(s) in Company
February 2007 Holding(s) in Company
February 2007 Notice of Results
December 2006 Total Voting Rights
November 2006 Symposium and Pipeline Update
July 2006 Significant Contract Win
July 2006 2006 Interim Statement
May 2006 2005 Annual Report
May 2006 In-Licencing Agreement
March 2006 2005 Preliminary Results
February 2006 Board Appointment
December 2005 Board Appointment
July 2005 2005 Interim Statement